(Q39878241)

15 September 2017

RNA interference for noggin enhances the biological activity of bone morphogenetic proteins in vivo and in vitro (English)

1 reference

15 September 2017

1 reference

Kazushi Takayama

1

1 reference

15 September 2017

Akinobu Suzuki

2

1 reference

15 September 2017

Tomoya Manaka

3

1 reference

15 September 2017

Susumu Taguchi

4

1 reference

15 September 2017

Yusuke Hashimoto

5

1 reference

15 September 2017

Yuuki Imai

6

1 reference

15 September 2017

Shigeyuki Wakitani

7

1 reference

15 September 2017

Kunio Takaoka

8

1 reference

15 September 2017

28 February 2009

1 reference

Journal of Bone and Mineral Metabolism

15 September 2017

1 reference

15 September 2017

27

1 reference

15 September 2017

4

1 reference

15 September 2017

402-411

1 reference

https://scigraph.springernature.com/pub.10.1007/s00774-009-0054-x

15 September 2017

0 references

cites work

Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts

1 reference

12 December 2020

Regulating bone growth and development with bone morphogenetic proteins

1 reference

12 December 2020

Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts

1 reference

12 December 2020

Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model.

1 reference

12 December 2020

Involvement of phosphodiesterase isozymes in osteoblastic differentiation

1 reference

12 December 2020

Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2.

1 reference

12 December 2020

Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation

1 reference

12 December 2020

A prostanoid receptor EP4 agonist enhances ectopic bone formation induced by recombinant human bone morphogenetic protein-2.

1 reference

12 December 2020

Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis

1 reference

12 December 2020

Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation

1 reference

12 December 2020

Expression profiles of BMP-related molecules induced by BMP-2 or -4 in muscle-derived primary culture cells

1 reference

12 December 2020

Bone morphogenetic proteins, their antagonists, and the skeleton

1 reference

12 December 2020

Randomized radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion: 2002 Volvo Award in clinical studies.

1 reference

12 December 2020

A phosphodiesterase inhibitor, pentoxifylline, enhances the bone morphogenetic protein-4 (BMP-4)-dependent differentiation of osteoprogenitor cells

1 reference

12 December 2020

Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin

1 reference

12 December 2020

Skeletal Overexpression of Noggin Results in Osteopenia and Reduced Bone Formation

1 reference

12 December 2020

Colocalization of noggin and bone morphogenetic protein-4 during fracture healing

1 reference

12 December 2020

Hepatocyte growth factor contributes to fracture repair by upregulating the expression of BMP receptors.

1 reference

12 December 2020

Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages

1 reference

12 December 2020

Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients

1 reference

12 December 2020

Phosphodiesterase inhibitors, pentoxifylline and rolipram, increase bone mass mainly by promoting bone formation in normal mice

1 reference

12 December 2020

Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model

1 reference

12 December 2020

Structural basis of BMP signalling inhibition by the cystine knot protein Noggin

1 reference

12 December 2020

Enhancement of bone morphogenetic protein-2-induced new bone formation in mice by the phosphodiesterase inhibitor pentoxifylline

1 reference

12 December 2020

Temporal and Spatial Expression Profiles of BMP Receptors and Noggin During BMP-2-Induced Ectopic Bone Formation

1 reference

12 December 2020

Bone morphogenetic proteins and their antagonists

1 reference

12 December 2020

Effect of phosphodiesterase inhibitor-4, rolipram, on new bone formations by recombinant human bone morphogenetic protein-2.

1 reference

12 December 2020

Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.

1 reference

12 December 2020

Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs

1 reference

12 December 2020

Clinical evaluation of recombinant human bone morphogenetic protein-2.

1 reference

12 December 2020

Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells

1 reference

12 December 2020

Enhancement of recombinant human bone morphogenetic protein-2 (rhBMP-2)-induced new bone formation by concurrent treatment with parathyroid hormone and a phosphodiesterase inhibitor, pentoxifylline

1 reference

12 December 2020

The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4

1 reference

12 December 2020

Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist

1 reference

12 December 2020

10.1007/S00774-009-0054-X

Identifiers

DOI

1 reference

release_igd4rh2bcfbxrfjivn2k6aolte

15 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/igd4rh2bcfbxrfjivn2k6aolte

24 November 2022

mapped directly with Wikidata item

1 reference